| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |